D.E. Shaw & Co’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$241M Buy
984,300
+184,700
+23% +$43M 0.14% 153
2025
Q4
$165M Buy
799,600
+181,500
+29% +$35.9M 0.09% 246
2025
Q3
$115M Sell
618,100
-315,100
-34% -$54M 0.06% 358
2025
Q2
$143M Buy
933,200
+77,600
+9% +$11.9M 0.1% 241
2025
Q1
$142M Buy
855,600
+451,100
+112% +$70.6M 0.13% 187
2024
Q4
$58.5M Sell
404,500
-59,500
-13% -$9.22M 0.04% 511
2024
Q3
$75.2M Sell
464,000
-54,700
-11% -$8.72M 0.06% 357
2024
Q2
$75.8M Sell
518,700
-201,500
-28% -$30M 0.07% 335
2024
Q1
$114M Sell
720,200
-754,800
-51% -$120M 0.1% 230
2023
Q4
$231M Buy
1,475,000
+213,000
+17% +$32.7M 0.2% 91
2023
Q3
$197M Buy
1,262,000
+85,300
+7% +$14.1M 0.21% 95
2023
Q2
$195M Buy
1,176,700
+326,600
+38% +$52.7M 0.2% 102
2023
Q1
$132M Buy
850,100
+441,600
+108% +$71.3M 0.14% 149
2022
Q4
$72.2M Sell
408,500
-264,500
-39% -$45.7M 0.08% 281
2022
Q3
$110M Buy
673,000
+245,000
+57% +$41.5M 0.13% 148
2022
Q2
$76M Buy
428,000
+168,000
+65% +$29.9M 0.09% 258
2022
Q1
$46.1M Sell
260,000
-268,200
-51% -$45.6M 0.04% 524
2021
Q4
$90.4M Buy
528,200
+307,900
+140% +$50.4M 0.07% 312
2021
Q3
$35.6M Sell
220,300
-244,300
-53% -$41.7M 0.03% 690
2021
Q2
$76.5M Buy
464,600
+429,900
+1,239% +$71.2M 0.07% 359
2021
Q1
$5.7M Sell
34,700
-5,300
-13% -$858K 0.01% 1753
2020
Q4
$6.29M Sell
40,000
-147,900
-79% -$21.8M 0.01% 1691
2020
Q3
$28M Buy
187,900
+13,400
+8% +$1.98M 0.03% 664
2020
Q2
$24.5M Sell
174,500
-132,100
-43% -$19.3M 0.03% 675
2020
Q1
$40.2M Sell
306,600
-126,400
-29% -$17.9M 0.06% 346
2019
Q4
$63.2M Buy
433,000
+106,800
+33% +$14.5M 0.07% 319
2019
Q3
$42.2M Buy
326,200
+161,700
+98% +$21.3M 0.05% 441
2019
Q2
$22.9M Sell
164,500
-253,200
-61% -$35M 0.03% 680
2019
Q1
$58.4M Buy
417,700
+253,600
+155% +$34M 0.08% 326
2018
Q4
$21.2M Sell
164,100
-175,900
-52% -$24.5M 0.03% 690
2018
Q3
$47M Sell
340,000
-119,100
-26% -$15.8M 0.06% 426
2018
Q2
$55.7M Buy
459,100
+48,300
+12% +$6.03M 0.07% 337
2018
Q1
$52.6M Sell
410,800
-145,800
-26% -$19.7M 0.07% 328
2017
Q4
$77.8M Buy
556,600
+67,300
+14% +$9.37M 0.11% 231
2017
Q3
$63.6M Buy
489,300
+45,100
+10% +$5.98M 0.1% 248
2017
Q2
$58.8M Sell
444,200
-7,600
-2% -$970K 0.1% 254
2017
Q1
$56.3M Sell
451,800
-291,400
-39% -$34.8M 0.1% 255
2016
Q4
$85.6M Buy
743,200
+15,100
+2% +$1.74M 0.15% 154
2016
Q3
$86M Sell
728,100
-76,300
-9% -$9.26M 0.15% 150
2016
Q2
$97.6M Buy
804,400
+300,400
+60% +$34.1M 0.18% 124
2016
Q1
$54.5M Buy
504,000
+78,700
+19% +$8.15M 0.1% 243
2015
Q4
$43.7M Sell
425,300
-12,200
-3% -$1.23M 0.07% 351
2015
Q3
$40.8M Buy
437,500
+127,100
+41% +$12.3M 0.06% 366
2015
Q2
$30.3M Sell
310,400
-479,000
-61% -$48M 0.05% 484
2015
Q1
$79.4M Buy
789,400
+161,800
+26% +$16.5M 0.12% 185
2014
Q4
$65.6M Buy
627,600
+11,100
+2% +$1.17M 0.08% 277
2014
Q3
$65.7M Sell
616,500
-10,700
-2% -$1.11M 0.09% 274
2014
Q2
$65.6M Sell
627,200
-283,300
-31% -$28.6M 0.09% 252
2014
Q1
$89.4M Hold
910,500
0.13% 162
2013
Q4
$83.4M Sell
910,500
-323,400
-26% -$29.8M 0.11% 179
2013
Q3
$107M Buy
1,233,900
+801,500
+185% +$71.9M 0.17% 109
2013
Q2
$37.1M Buy
+432,400
New +$36.7M 0.07% 303

Other funds holding JNJ

D.E. Shaw & Co's JNJ Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Johnson & Johnson (JNJ) stake by 13% in Q1 2026, selling an estimated $27.7M and leaving 764,504 shares worth $187M. The position accounts for 0.11% of the portfolio, ranked #209.

D.E. Shaw & Co first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $965M in Q3 2019. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • D.E. Shaw & Co held 764,504 shares of Johnson & Johnson worth $187M as of Q1 2026.
  • D.E. Shaw & Co sold 118,999 Johnson & Johnson shares in Q1 2026, an estimated $27.7M.
  • Johnson & Johnson made up 0.11% of D.E. Shaw & Co's portfolio in Q1 2026, its #209 holding.
  • D.E. Shaw & Co first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • D.E. Shaw & Co's Johnson & Johnson position peaked at $965M in Q3 2019.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.